Pacylex Pharmaceuticals Inc. — Form D
Pacylex Pharmaceuticals Inc. of Calgary, A0, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-14. The offering totals $7.2M, of which $7.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-06-14
- Form: D
- Accession: 0001567619-21-012046
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $7.2M
- Amount sold: $7.2M
- Investors: 6
- Date of first sale: 2021-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-402780
Issuer
- Name: Pacylex Pharmaceuticals Inc.
- CIK: 0001866841
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 400 3rd Avenue SW, Calgary, A0, T2P 4H2
- Phone: 780-264-4295
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ajit G Gill | Director | Calgary, A0 |
| Michael Weickert | Director | Calgary, A0 |
| Michael Weickert | Executive Officer | Calgary, A0 |
| Nola G Masterson | Director | Calgary, A0 |
| Luc G Berthiaume | Director | Calgary, A1 |
| John G Mackey | Director | Calgary, A0 |
| Ryan G Heit | Executive Officer | Calgary, A0 |
| Cindy Jacobs | Director | Calgary, A0 |
| Mark Huson | Director | Calgary, A0 |
Other filings by this issuer (1)
More